SPECIFIC HEALTH BENEFITS
Heart Health Many extensive medical studies show that Omega-3 fish oils are good for overall heart and cardiovascular health 1-20. Omega-3 also supports healthy triglyceride levels 21-23 and is recommended by both The American Heart Association and The National Institutes of Health (NIH). CoQ10 has also been shown to support heart health.* 24,25
Brain Health DHA, one of the critical fatty acids in Omega-3, is the essential building block of the brain. DHA comprises over 30% of the fatty acids found in the brain and plays a vital role in how our cells function. Higher levels of DHA have been shown to support healthy brain development.26-28 Also, research in the last few years has revealed that diets rich in Omega-3 support a healthy emotional balance and positive mood,29-32 and may help to maintain a healthy mental status in later years.*33-35
Prenatal and Children Health Omega-3, especially DHA, is crucial for the healthy development of babies and children’s brain and eyes.26-28,36-39 98% of baby formulas are now fortified with DHA. Omega-3 DHA helps to support children overall growth and development 26.*
Joint Health & Mobility Omega-3 fatty acids may block some of the body’s processes that limit joint health and freedom of movement and have been found to help with joint stiffness and associated discomfort. 40-44 More than a dozen studies in the last 10 years have found that a diet with a more balanced intake of Omega-3 to Omega-6 fatty acids may help maintain healthy joints. *45
1. Din, JN, et al. Dietary intervention with oil rich fish reduces platelet-monocyte
aggregation in man. Atherosclerosis, Vol. 197, 2008, pp. 290-96
2. Biscione F. et al. Cardiovascular effects of omega-3 free fatty acids.
Curr Vasc Pharmacol. Vol. 5, April 2007, pp. 163-172.
3. Kris-Etherton, PM, et al. Fish consumption, fish oil, omega-3 fatty acids, and
cardiovascular disease. Circulation, Vol. 106, November 19, 2002, pp. 2747-57
4. Harris, W.S. et al. Blood Omega-3 and Trans Fatty Acids in Middle-Aged Acute
Coronary Syndrome Patients. American Journal of Cardiology, 2007, Vol. 99,
5. Salachas, Anastasios, et al. Effects of low-dose fish oil concentrate on angina,
exercise tolerance time, serum triglycerides, and platelet function. Angiology, Vol.
45, December 1994, pp. 1023-31
6. Calder, Philip C. New evidence in support of the cardiovascular benefit of long-chain
n-3 fatty acids. Italian Heart Journal, Vol. 4, July 2003, pp. 427-29
7. Thies, Frank, et al. Association of n-3 polyunsaturated fatty acids with stability of
atherosclerotic plaques: a randomized controlled trial. The Lancet, Vol. 361,
February 8, 2003, pp. 477-85
8. Gissi-HF investigators, Effect of n-3 polyunsaturated fatty acids in patients with
chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-
controlled trial. The Lancet, Vol. 372, October 4, 2008, pp. 1223-30.
9. Metcalf, RG, et al. Effect of dietary n-3 polyunsaturated fatty acids on the
inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy.
American Journal of Cardiology, Vol. 101, 2008, pp. 758-61
10. London, B, et al. Omega-3 fatty acids and cardiac arrhythmias: Prior studies
and recommendations for future research. Circulation, Vol. 116, September 2,
2007, pp. 320-35
11. De Caterina, Raffaele, et al. Antiarrhythmic effects of omega-3 fatty acids:
from epidemiology to bedside. American Heart Journal, Vol. 146, September 2003,
12. Mozaffarian, D, et al. Dietary fish and omega-3 fatty acid consumption and heart
rate variability in US adults. Circulation, Vol. 117, March 4, 2008, pp. 1130-37
13. Harris, WS, et al. Omega-3 fatty acids and coronary heart disease risk: clinical
and mechanistic perspectives. Atherosclerosis, Vol. 197, March 2008, pp. 12-24.
14. Wang, C. et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-
linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-
prevention studies: a systematic review. The American Journal of Clinical
Nutrition, Vol. 84, July 1, 2006, pp. 5-17
15. Harper, C.R. and Jacobson, T.A. Usefulness of Omega-3 Fatty Acids and the
Prevention of Coronary Heart Disease. American Journal of Cardiology, Vol. 96,
December 2005, pp. 1521-29
16. He, K, et al. Fish consumption and risk of stroke in men. Journal of the American Medical Association, Vol. 288, December 25, 2002, pp. 3130-36
17. Iso, Hiroyasu, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. Journal of the American Medical Association, Vol. 285, January 17, 2001, pp. 304-12
18. Tomiyama. H, et al. Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia?: A preliminary study. Hypertension Research, Vol. 28, August 2005, pp. 651-5
19. Zampelas, A. et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: The ATTICA Study. Journal of the American College of Cardiology, Vol. 46, July 2005, pp. 120-24
20. Toft, Ingrid, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. Annals of Internal Medicine, Vol. 123, No. 12, December 15, 1995, pp. 911- 18
21. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid
concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin
Pharmacother 2008 May;9(7):1237-48.
22. Brunton S, Collins N. Differentiating prescription omega-3-acid ethyl esters
(P-OM3) from dietary-supplement omega-3 fatty acids. Curr Med Res Opin 2007
23. Harris, William S. n-3 fatty acids and serum lipoproteins: human studies.
American Journal of Clinical Nutrition, Vol 65 (suppl), 1997, pp. 1645S-54S
24. Langsjoen, PH et al. Overview of the use of CoQ10 in cardiovascular disease.
Biofactors, Vol. 9, 1999, pp.273-84.
25. Molyneux SL, et. Al. Coenzyme Q10: an independent predictor of mortality in
chronic heart failure. J. Am Coll Cardiol. 2008 Oct. 28; 52(18):1435-41
26. Oken E, Osterdal ML, Gillman MW et al. Associations of maternal fish intake during
pregnancy and breastfeeding duration with attainment of developmental mile
stones in early childhood: a study from the Danish National Birth Cohort. Am J
Clin Nutr 2008 September; 88(3):789-96.
27. Innis SM. Dietary omega-3 fatty acids and the developing brain.
Brain Research, October 27, 2008, pp. 35-43.
28. Carlson, S.E. Long-chain polyunsaturated fatty acids and development of human
infants. Acta Paediatr Suppl, No. 430, 1999, pp. 72-7
29. Nemets, Hanah, et al. Omega-3 treatment of childhood depression. American
Journal of Psychiatry, Vol. 163, June 2006, pp. 1098-1100
30. Small, Meredith F. The happy fat. New Scientist, August 24, 2002, pp. 34-37
31. Bruinsma, Kristen A. and Taren, Douglas L. Dieting, essential fatty acid intake, and
depression. Nutrition Reviews, Vol. 58, April 2000, pp. 98-108
32. Edwards, Rhian, et al. Omega-3 polyunsaturated fatty acid levels in the diet and
in red blood cell membranes of depressed patients. Journal of Affective Disorders,
Vol. 48, 1998, pp. 149-55
33. Van Gelder, BM, et al. Fish consumption, n-3 fatty acids, and subsequent 5-y
cognitive decline in elderly men. American Journal of Clinical Nutrition, Vol. 85,
2007, pp. 1142-47
34. Freund-Levi, Y, et al. Omega-3 fatty acid treatment in 174 patients with mild to
moderate Alzheimer disease. Archives of Neurology, Vol. 63, October 2006, pp.
35. Morris, MC, et al. Consumption of fish and n-3 fatty acids and risk of incident of
Alzheimer’s disease. Archives of Neurology, Vol. 60, July 2003, pp. 940-46
36. Koletzko B, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. Journal of Perinatal Medicine, Vol. 36, pp. 5-14
37. Judge, MP, et al. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy. American Journal of Clinical Nutrition, Vol. 85, 2007, pp. 1572-77
38. Dunstan, JA, et al. Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy. Archives of Disease in Childhood. Fetal and Neonatal Edition. 2006 December 21 [Epub ahead of print]
39. Helland, Ingrid B., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics, Vol. 111, January 2003, pp. 39-44
40. Darlington, L. Gail and Stone, Trevor W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. British Journal of Nutrition, Vol. 85, March 2001, pp. 251-69
41. Volker, Dianne, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. Journal of Rheumatology, Vol. 27, October 2000, pp. 2343-46
42. Cleland, Leslie G. and James, Michael J. Fish oil and rheumatoid arthritis: anti-inflammatory and collateral health benefits. Journal of Rheumatology, Vol. 27, October 2000, pp. 2305-06 (editorial)
43. Goldberg RJ and Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, Vol.129, May 2007, pp. 210-23.
44. Maroon, J.C. et al. Omega-3 Fatty Acids as an Anti-inflammatory: an Alternative to
Nonsteroidal Anti-inflammatory Drugs for Discogenic Pain. Surgical Neurology,
2006, Vol. 65, pp. 326-31
45. Watkins, BA, et al. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood), Vol. 226, June 2001, pp. 485-97.
1. Effects of Omega-3 Fatty Acids on Resting Heart Rate, Simopoulos AP. 2007.
2. Omega-3 Fatty Acids and Athletics. Curr Sports Med Rep. 6:230-6.
3. Rate Recovery After Exercise, and Heart Rate Variability in Men With Healed Myocardial Infarctions and Depressed Ejection Fractions. The American Journal of Cardiology, 2006 Volume 97, Issue 8, Pages 1127-1130 J. O’Keefe, Jr, H. Abuissa, A. Sastre, D. Steinhaus, W.Harris
1. American Heart Association, Fish and Omega-3 Fatty Acids, http://www.americanheart.org/presenter.jhtml?identifier=4632
2. GIZZI Prevenzione Trial: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999;354:447–55.
3. Singh RB, Wander GS, Rastogi A, et al. Randomized double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1998;12:347–53.
4. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong J-Y, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Human Hypertension 21: 297-306, 2007
1. Ahmed W, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009; 153(1): 11-6.
2. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fiber intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989 Sep 30;2(8666):757-61
3. Maes M, Christophe A, Delanghe J, et al. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-91
4. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):233-9
5. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3
polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996;174:1335-8
6 Linden KG, Weinstein GD. Psoriasis: current perspectives with an emphasis on treatment. Am J Med 1999;107:595-605
7. Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5
8. Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:72-7
9. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007;167:1159-65